ERBB2 and breast cancer: Due to the lack of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2), TNBC has a higher recurrence rate and limited response to conventional treatments compared to other subtypes of breast cancer, making it the subtype with the worst clinical prognosis [2,3].